Oluwole S F, Jin M X, Chowdhury N C, Ohajekwe O A
Department of Surgery, College of Physicians and Surgeons of Columbia University, New York, New York 10032.
Transplantation. 1994 Nov 27;58(10):1077-81.
Our finding that intrathymic inoculation of resting T cells but not dendritic cells induces donor-specific unresponsiveness to organ allografts led us to hypothesize that presentation of MHC class I alloantigens by thymic antigen-presenting cells to T cell precursors during their ontogeny may convey a tolerogenic signal to the recipient. In this study, we examined whether intrathymic inoculation of soluble antigen obtained from 3M KCl extracts of allogeneic T cells could induce donor-specific unresponsiveness to islet allografts in the Lewis-to-WF rat combination. Our results showed that while intrathymic injection of 0.5 mg soluble antigen on day -7 relative to islet transplantation caused acute graft rejection, intrathymic inoculation of 1.0 mg soluble antigen significantly prolonged the survival of Lewis islet allografts from 10.3 +/- 1.1 days in controls to 53.5 +/- 15.6 days (P < 0.001) in naive (nonimmunosuppressed) STZ (streptozotocin)-induced diabetic WF recipients. In contrast, intrathymic inoculation of 2.0 or 4.0 mg soluble Ag on day -7 led to indefinite Lewis islet survival (> 150 days) in all naive diabetic WF recipients; a finding that suggests that 2.0 mg soluble Ag is the optimal effective dose of intrathymic inoculum required to induce donor-specific unresponsiveness in naive recipients in this model. This finding could not be reproduced by intravenous injection of 2.0 mg soluble Ag, thus confirming the privileged position of the thymus in the induction of Ag-specific unresponsiveness. Third-party (BN) islet allografts were rejected in an acute fashion in similarly prepared recipients. Our results suggest that (1) intrathymic inoculation of soluble Ag, unlike cellular Ag, induces donor-specific unresponsiveness to islet allografts without the use of transient recipient immunosuppression; (2) induction of specific unresponsiveness appears to be dose dependent; and (3) the tolerogenic effect of soluble Ag is dependent on the indirect pathway of Ag-presentation in the thymus in the absence of donor antigen-presenting cells in the inoculum. This novel approach of thymic reeducation of adult animals by the deliberate intrathymic inoculation of soluble major histocompatibility complex Ag without the use of recipient immunosuppression may have therapeutic potential in the induction of transplantation tolerance.
我们的研究发现,胸腺内接种静息T细胞而非树突状细胞可诱导对器官同种异体移植物的供体特异性无反应性,这使我们推测,胸腺抗原呈递细胞在T细胞前体发育过程中向其呈递MHC I类同种异体抗原,可能会向受体传递一个致耐受性信号。在本研究中,我们检测了胸腺内接种从同种异体T细胞的3M KCl提取物中获得的可溶性抗原,是否能在Lewis大鼠到WF大鼠的组合中诱导对胰岛同种异体移植物的供体特异性无反应性。我们的结果显示,相对于胰岛移植,在第-7天胸腺内注射0.5mg可溶性抗原会导致急性移植排斥反应,而胸腺内接种1.0mg可溶性抗原可显著延长Lewis胰岛同种异体移植物在未免疫抑制的(非免疫抑制的)链脲佐菌素(STZ)诱导的糖尿病WF受体中的存活时间,从对照组的10.3±1.1天延长至53.5±15.6天(P<0.001)。相比之下,在第-7天胸腺内接种2.0或4.0mg可溶性抗原,可使所有未免疫抑制的糖尿病WF受体中的Lewis胰岛无限期存活(>150天);这一发现表明,2.0mg可溶性抗原是在该模型中诱导未免疫抑制受体产生供体特异性无反应性所需的胸腺内接种物的最佳有效剂量。静脉注射2.0mg可溶性抗原无法重现这一结果,从而证实了胸腺在诱导抗原特异性无反应性方面的特殊地位。在同样制备的受体中,第三方(BN)胰岛同种异体移植物会被急性排斥。我们的结果表明:(1)与细胞抗原不同,胸腺内接种可溶性抗原可在不使用短暂受体免疫抑制的情况下,诱导对胰岛同种异体移植物的供体特异性无反应性;(2)特异性无反应性的诱导似乎具有剂量依赖性;(3)在接种物中不存在供体抗原呈递细胞的情况下,可溶性抗原的致耐受性效应依赖于胸腺内抗原呈递的间接途径。这种通过在成年动物胸腺内故意接种可溶性主要组织相容性复合体抗原而不使用受体免疫抑制来进行胸腺再教育的新方法,可能在诱导移植耐受性方面具有治疗潜力。